• Here's Why Shares in Novo Nordisk Rival, Agios Pharmaceutical, Soared This Week Yahoo Finance Fri, 10 Jul 2026 11:55:00 GMT
• Is Agios Pharmaceuticals (AGIO) A Bargain After FDA Priority Review For Mitapivat? Yahoo Finance Thu, 09 Jul 2026 12:13:27 GMT
• Agios Pharmaceuticals (AGIO) Is Up 13.8% After FDA Grants Priority Review To Mitapivat In Sickle Cell Disease Yahoo Finance Thu, 09 Jul 2026 10:13:44 GMT
• AGIO's Filing for Mitapivat in SCD Gets FDA's Priority Tag, Stock Up Yahoo Finance Singapore Wed, 08 Jul 2026 14:32:00 GMT
• Strength Seen in Agios Pharmaceuticals (AGIO): Can Its 17.7% Jump Turn into More Strength? Yahoo Finance Wed, 08 Jul 2026 14:29:00 GMT
• A Quick Look at Today's Ratings for Agios Pharmaceuticals(AGIO.US), With a Forecast Between $41 to $54 富途牛牛 Wed, 08 Jul 2026 13:00:01 GMT
• What Is Driving Focus on Agios Pharmaceuticals (NASDAQ:AGIO)? Kalkine Media Wed, 08 Jul 2026 08:27:00 GMT
• AGIO Stock Jumps As Mitapivat Trial Data Fuels Bullish Targets timothysykes.com Tue, 07 Jul 2026 21:04:00 GMT
• Why This Novo Nordisk Rival Just Soared To A Profit-Taking Zone Investor's Business Daily Tue, 07 Jul 2026 20:11:00 GMT
• Agios Pharmaceuticals (NASDAQ:AGIO) pops as FDA review moves price above average target TechStock² Tue, 07 Jul 2026 19:35:01 GMT
• H.C. Wainwright Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Maintains Target Price $54 Moomoo Tue, 07 Jul 2026 17:37:14 GMT
• Here's Why Agios Pharmaceuticals Stock Soared Today (Hint: It's FDA-Related) Yahoo Finance Tue, 07 Jul 2026 16:52:49 GMT
• agio maintained by rbc capital -- price target raised to $32 GuruFocus Tue, 07 Jul 2026 16:48:30 GMT
• Agios Pharmaceuticals (AGIO) Receives Priority Review from FDA f GuruFocus Tue, 07 Jul 2026 16:40:25 GMT
• AGIO Stock Jumps As Mitapivat Sickle Cell Data Fuels Hype StocksToTrade Tue, 07 Jul 2026 16:34:00 GMT
• AGIO Stock Hits Over 7-Month Highs – FDA Catalyst, ‘Seasonally Strong’ Q2 Earnings Estimate Drive Optimism TradingView Tue, 07 Jul 2026 16:16:57 GMT
• Agios Pharmaceuticals (AGIO) Secures FDA Priority Review for Mit GuruFocus Tue, 07 Jul 2026 16:02:07 GMT
• After receiving priority review designation from the FDA for its sickle cell disease treatment, Agios Pharmaceuticals, Inc. shares... Bitget Tue, 07 Jul 2026 15:53:17 GMT
• FDA Grants Priority Review to Agios’ Mitapivat sNDA for Sickle Cell Disease HCP Live Tue, 07 Jul 2026 15:41:29 GMT
• Agios Pharmaceuticals Shares Rise After FDA Grants Priority Review for Sickle Cell Treatment marketscreener.com Tue, 07 Jul 2026 15:18:27 GMT
• BofA Securities Adjusts Price Target on Agios Pharmaceuticals to $46 From $40, Maintains Buy Rating Moomoo Tue, 07 Jul 2026 14:49:33 GMT
• DigitalOcean, Agios Pharmaceuticals, Kingsoft Cloud And Other Big Stocks Moving Higher On Tuesday Benzinga Tue, 07 Jul 2026 14:00:38 GMT
• Agios Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $42.62, Implies 14% Upside TradingView Tue, 07 Jul 2026 13:20:03 GMT
• FDA accepts Agios sNDA for mitapivat in sickle cell disease Investing.com Tue, 07 Jul 2026 12:20:43 GMT
• AGIO Maintained by B of A Securities -- Price Target Raised to $46 GuruFocus Tue, 07 Jul 2026 12:06:39 GMT
• Agios Pharmaceuticals (AGIO) Gains FDA Priority Review for Pyruk GuruFocus Tue, 07 Jul 2026 12:06:38 GMT
• Agios Says US FDA Grants Priority Review for Mitapivat to Treat Sickle Cell Disease Moomoo Tue, 07 Jul 2026 11:58:14 GMT
• Agios Pharmaceuticals (AGIO) Receives FDA Priority Review for Mi GuruFocus Tue, 07 Jul 2026 11:46:35 GMT
• RBC Capital Adjusts Agios Pharmaceuticals PT to $32 From $28, Maintains Sector Perform Rating marketscreener.com Tue, 07 Jul 2026 11:44:01 GMT
• Agios gains FDA priority review for Pyrukynd label expansion Seeking Alpha Tue, 07 Jul 2026 11:37:02 GMT
• U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease The Manila Times Tue, 07 Jul 2026 11:21:54 GMT
• FDA puts Agios' sickle cell drug on fast track to Nov. 1 review date Stock Titan Tue, 07 Jul 2026 11:00:00 GMT
• Pulling the plug on cancer: Agios Pharmaceuticals, Revolution Medicines, and Vidac Pharma Stockhouse Tue, 07 Jul 2026 05:43:41 GMT
• Price to sales forward of Agios Pharmaceuticals, Inc. – MUN:8AP TradingView Tue, 07 Jul 2026 05:02:18 GMT
• Agios Pharmaceuticals (AGIO) Could Be 8% Below Fair Value On Growth Index Shift simplywall.st Sun, 05 Jul 2026 19:46:00 GMT
• the technical signals behind (agio) that institutions follow Stock Traders Daily Sun, 05 Jul 2026 17:56:02 GMT
• Price to book forward of Agios Pharmaceuticals, Inc. – NASDAQ:AGIO TradingView Sun, 05 Jul 2026 06:12:44 GMT
• Price to earnings forward of Agios Pharmaceuticals, Inc. – NASDAQ:AGIO TradingView Fri, 03 Jul 2026 11:18:57 GMT
• Enterprise value to revenue forward of Agios Pharmaceuticals, Inc. – NASDAQ:AGIO TradingView Fri, 03 Jul 2026 11:12:47 GMT
• Enterprise value to EBIT forward of Agios Pharmaceuticals, Inc. – NASDAQ:AGIO TradingView Fri, 03 Jul 2026 07:47:23 GMT
• Agios Pharmaceuticals: CMO Sarah Gheuens sells $150,502 in stock Investing.com Thu, 02 Jul 2026 20:17:47 GMT
• Agios (NASDAQ: AGIO) CMO nets shares after RSU vesting and tax sale Stock Titan Thu, 02 Jul 2026 20:03:46 GMT
• Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gheuens Sarah Moomoo Thu, 02 Jul 2026 20:03:42 GMT
• agio (nasdaq: agio) affiliate notifies plan to offer 4,007 shares via broker Stock Titan Wed, 01 Jul 2026 20:08:59 GMT
• How Agios Pharmaceuticals' Shift Into Russell Growth Indices Will Impact Agios Pharmaceuticals (AGIO) Investors simplywall.st Wed, 01 Jul 2026 13:42:06 GMT
• Agios Pharmaceuticals, Inc.(NasdaqGS: AGIO) dropped from Russell 2000 Defensive Index marketscreener.com Mon, 29 Jun 2026 21:18:30 GMT
• agios pharmaceuticals, inc.(nasdaqgs:agio) added to russell small cap comp growth benchmark marketscreener.com Mon, 29 Jun 2026 20:43:34 GMT
• agios pharmaceuticals, inc.(nasdaqgs: agio) added to russell 2500 growth benchmark marketscreener.com Mon, 29 Jun 2026 19:22:53 GMT
• agios pharmaceuticals to announce q2 2026 results on july 30 scanx.trade Mon, 29 Jun 2026 12:01:02 GMT
• agios to host second quarter 2026 financial results conference call and webcast on july 30 at ... Caledonian Record Mon, 29 Jun 2026 11:00:50 GMT
• agios pharmaceuticals, inc.(nasdaqgs:agio) dropped from russell 2000 value-defensive index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• Agios Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:AGIO) TradingView Fri, 26 Jun 2026 12:56:10 GMT
• Agios Pharmaceuticals Insider Lowered Holding By 91% During Last Year Moomoo Fri, 26 Jun 2026 11:52:37 GMT
• Agios Pharmaceuticals (AGIO) Could Be 11% Undervalued Following Its Rare Disease Growth Narrative simplywall.st Thu, 25 Jun 2026 07:00:00 GMT
• here's why agios pharmaceuticals stock slumped this week (and what investors have to look forward to in 2026) AOL.com Thu, 25 Jun 2026 06:20:00 GMT
• Precision Trading with Agios Pharmaceuticals Inc. (AGIO) Risk Zones Stock Traders Daily Wed, 24 Jun 2026 16:48:03 GMT
• truist financial maintains agios pharmaceuticals(agio.us) with buy rating, announces target price $36 富途牛牛 Wed, 24 Jun 2026 10:08:27 GMT
• A Quick Look at Today's Ratings for Agios Pharmaceuticals(AGIO.US), With a Forecast Between $36 to $54 Moomoo Wed, 24 Jun 2026 09:27:26 GMT
• agios pharmaceuticals (agio) is up 10.3% after new mitapivat phase 3 data and share filing – has the bull case changed? Sahm Wed, 24 Jun 2026 07:27:34 GMT
• agios (nasdaq: agio) director receives new options and rsu awards Stock Titan Tue, 23 Jun 2026 21:23:29 GMT
• agios (agio) director scadden exercises rsus and receives new stock option and rsu awards Stock Titan Tue, 23 Jun 2026 21:21:05 GMT
• agios (nasdaq: agio) grants viswanadhan 6,000 rsu and performance share units Stock Titan Tue, 23 Jun 2026 21:18:54 GMT
• agios (nasdaq: agio) cmo awarded rsus, hits milestone for performance units Stock Titan Tue, 23 Jun 2026 21:16:19 GMT
• agios (nasdaq: agio) cfo receives rsus and milestone-based performance share units Stock Titan Tue, 23 Jun 2026 21:14:36 GMT
• agios pharmaceuticals (agio) is up 10.3% after new mitapivat phase 3 data and share filing – has the bull case changed? simplywall.st Tue, 23 Jun 2026 15:52:46 GMT
• Agios Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Goff Brian Moomoo Tue, 23 Jun 2026 07:00:00 GMT
• [form 4] agios pharmaceuticals, inc. insider trading activity Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• agios pharmaceuticals (agio) director reports new equity awards and rsu vesting Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• agios (nasdaq: agio) director exercises rsus and gains new equity awards Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• agios (nasdaq: agio) director receives new stock options and rsu awards Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• agios (agio) director maykin ho exercises rsus and receives new equity awards Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• agios (nasdaq: agio) director receives stock options, rsus and exercises units Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• agios (nasdaq: agio) director reports rsu exercise and new equity grants Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• agios (nasdaq: agio) ceo brian goff receives 39,000 stock-based awards Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• agios pharmaceuticals inc (agio) institutional confidence TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• agios pharmaceuticals inc (agio) valuation: pe, pb & fair value analysis TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• agios pharmaceuticals (agio) rallies 3.26% as stock nears key resistance level - institutional flow picks Město Břeclav Fri, 19 Jun 2026 22:43:11 GMT
• agios pharmaceuticals (nasdaq: agio) boosts 2023 stock plan by 2m shares Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• agio stock surges 35% in six months: what's driving it? Yahoo Finance Thu, 18 Jun 2026 07:00:00 GMT
• agios pharmaceuticals inc (agio) institutional confidence TradingKey Thu, 18 Jun 2026 01:23:53 GMT
• agios pharmaceuticals inc (agio) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 01:23:51 GMT
• agios pharmaceuticals inc (agio) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 01:23:48 GMT
• agios pharmaceuticals inc (agio) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 01:21:17 GMT
• agios pharmaceuticals inc (agio) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 01:20:56 GMT
• agios pharmaceuticals inc (agio) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 00:53:25 GMT
• agios pharmaceuticals inc (agio) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 18:57:55 GMT
• agios pharmaceuticals inc (agio) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 18:57:43 GMT
• td cowen maintains agios pharmaceuticals(agio.us) with buy rating Moomoo Wed, 17 Jun 2026 07:00:00 GMT
• agios pharmaceuticals (agio) stock could be 22% undervalued after rise up phase 3 data Sahm Wed, 17 Jun 2026 07:00:00 GMT
• agios pharmaceuticals touts mitapivat gains despite sickle cell pain miss MSN Tue, 16 Jun 2026 20:34:51 GMT
• agios (nasdaq: agio) director converts 1,976 rsus, holds 8,049 shares Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• agios (agio) director catherine owen adams converts 1,976 rsus into common stock Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• agios pharmaceuticals inc (agio) institutional confidence TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• agios pharmaceuticals inc (agio) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• agios pharmaceuticals inc (agio) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• agios pharmaceuticals inc (agio) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• agios pharmaceuticals (agio) is up 7.4% after mitapivat rise up data in sickle cell disease - has the bull case changed? simplywall.st Mon, 15 Jun 2026 10:55:45 GMT
• Agios Pharmaceuticals, Inc. (AGIO) Discusses New Data and Strategic Expansion in Rare Hematology at EHA Investor Event - Slideshow... Seeking Alpha Mon, 15 Jun 2026 07:00:00 GMT
• truist financial maintains agios pharmaceuticals(agio.us) with buy rating, announces target price $36 Moomoo Mon, 15 Jun 2026 07:00:00 GMT
• h.c. wainwright maintains agios pharmaceuticals(agio.us) with buy rating, raises target price to $54 Moomoo Mon, 15 Jun 2026 07:00:00 GMT
• agios pharmaceuticals (agio) reports promising results from phas GuruFocus Mon, 15 Jun 2026 01:20:52 GMT
• agios pharmaceuticals (agio) reports promising results from phas GuruFocus Sun, 14 Jun 2026 21:06:31 GMT
• agio: mitapivat shows durable efficacy in rare hematology, supporting growth and pipeline expansion TradingView Sat, 13 Jun 2026 16:50:39 GMT
• technical reactions to agio trends in macro strategies Stock Traders Daily Sat, 13 Jun 2026 15:36:01 GMT
• mitapivat shows strong benefits in sickle cell disease, reducing transfusions and improving symptoms in phase 3 trial. Pluang Sat, 13 Jun 2026 13:39:26 GMT
• agios showcases rise up phase 3 results at eha 2026 plenary session reinforcing strong ... Caledonian Record Sat, 13 Jun 2026 13:02:30 GMT
• Agios Pharmaceuticals Touts Mitapivat Gains Despite Sickle Cell Pain Miss Yahoo Finance Sat, 13 Jun 2026 07:00:00 GMT
• agios pharmaceuticals reports positive phase 3 results for mitapivat in sickle cell disease, highlighting hemoglobin response and ... Quiver Quantitative Sat, 13 Jun 2026 07:00:00 GMT
• sickle cell patients needed fewer transfusions with agios pill in phase 3 Stock Titan Sat, 13 Jun 2026 07:00:00 GMT
• agios presents detailed mitapivat trial results for sickle cell Investing.com Sat, 13 Jun 2026 07:00:00 GMT
• bofa securities maintains agios pharmaceuticals(agio.us) with buy rating, maintains target price $40 Moomoo Fri, 12 Jun 2026 07:00:00 GMT
• j.p. morgan maintains agios pharmaceuticals(agio.us) with hold rating, maintains target price $31 Moomoo Thu, 11 Jun 2026 07:00:00 GMT
• capital international investors buys new position in agios pharmaceuticals, inc. $agio MarketBeat Wed, 10 Jun 2026 07:56:15 GMT
• agios pharmaceuticals, inc. $agio shares bought by bnp paribas financial markets MarketBeat Wed, 10 Jun 2026 07:24:51 GMT
• ‘disciplined’ $665m deal moves oscotec’s cevidoplenib to agios BioWorld News Tue, 09 Jun 2026 16:00:00 GMT
• agio secures global rights to late-stage rare blood disorder candidate MSN Tue, 09 Jun 2026 09:21:23 GMT
• alpha thalassemia market emerging as a high-growth healthcare investment space through 2036 – delveinsight | forma therapeutics, g... Barchart.com Tue, 09 Jun 2026 00:22:11 GMT
• bofa securities maintains agios pharmaceuticals(agio.us) with buy rating, maintains target price $40 Moomoo Mon, 08 Jun 2026 11:32:00 GMT
• erste asset management gmbh acquires 40,000 shares of agios pharmaceuticals, inc. $agio MarketBeat Mon, 08 Jun 2026 08:34:21 GMT
• the week in pharma: action, reaction and insight – week to june 5, 2026 The Pharma Letter Sun, 07 Jun 2026 10:09:09 GMT
• agio secures global rights to late-stage rare blood disorder candidate MSN Sun, 07 Jun 2026 06:36:08 GMT
• agios pharmaceuticals | 144: notice of proposed sale of securities pursuant to rule 144 Moomoo Sat, 06 Jun 2026 07:29:56 GMT
• agios slides after discontinuing development of tebapivat in myelodysplastic syndromes (agio) MSN Sat, 06 Jun 2026 07:23:46 GMT
• ‘disciplined’ $665m deal moves oscotec’s cevidoplenib to agios BioWorld News Fri, 05 Jun 2026 16:00:00 GMT
• why agios pharmaceuticals (agio) is down 5.4% after overhauling its hematology portfolio - and what's next simplywall.st Fri, 05 Jun 2026 15:36:14 GMT
• after $665 mil. agios deal, oscotec maps 2028 phase 3 path for blood disorder drug koreabiomed.com Thu, 04 Jun 2026 07:00:00 GMT
• a look at agios pharmaceuticals (agio) valuation after the cevidoplenib licensing agreement Sahm Thu, 04 Jun 2026 07:00:00 GMT
• oscotec seals 1 trillion-won cevidoplenib deal, targets korea-linked approvals by 2030 - chosunbiz Chosunbiz Thu, 04 Jun 2026 05:11:00 GMT
• agio secures global rights to late-stage rare blood disorder candidate MSN Thu, 04 Jun 2026 01:38:59 GMT
• td cowen maintains agios pharmaceuticals(agio.us) with buy rating 富途牛牛 Wed, 03 Jun 2026 18:35:17 GMT
• how the tebapivat setback is reframing the story for agios pharmaceuticals (agio) Yahoo Finance Wed, 03 Jun 2026 07:00:00 GMT
• td cowen maintains agios pharmaceuticals(agio.us) with buy rating 富途牛牛 Tue, 02 Jun 2026 21:31:00 GMT
• analysts are bullish on top healthcare stocks: agios pharma (agio), cogent biosciences (cogt) The Globe and Mail Tue, 02 Jun 2026 12:56:00 GMT
• agios inks global licensing agreement with oscotec The Pharma Letter Tue, 02 Jun 2026 12:31:31 GMT
• agio secures global rights to late-stage rare blood disorder candidate Yahoo Finance Tue, 02 Jun 2026 07:00:00 GMT
• goldman sachs maintains agios pharmaceuticals(agio.us) with hold rating, raises target price to $32 Moomoo Tue, 02 Jun 2026 07:00:00 GMT
• oscotec’s cevidoplenib licensing deal puts spotlight on 1st-line itp expansion potential koreabiomed.com Tue, 02 Jun 2026 04:57:01 GMT
Agios Pharmaceuticals, Inc(NASDAQ:AGIO) 
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers TIBSOVO (ivosidenib), an oral targeted inhibitor for treating adult patients with relapsed or refracto...
Website: http://www.agios.com
Founded: 2008
Full Time Employees: 536
Sector: Healthcare
Industry: Biotechnology